NO941477L - - Google Patents
Info
- Publication number
- NO941477L NO941477L NO941477A NO941477A NO941477L NO 941477 L NO941477 L NO 941477L NO 941477 A NO941477 A NO 941477A NO 941477 A NO941477 A NO 941477A NO 941477 L NO941477 L NO 941477L
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK9100324 | 1991-10-24 | ||
| PCT/DK1992/000307 WO1993008206A1 (en) | 1991-10-24 | 1992-10-21 | Novel 2,6-disubstituted purine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO941477D0 NO941477D0 (no) | 1994-04-22 |
| NO941477L true NO941477L (OSRAM) | 1994-06-23 |
| NO300461B1 NO300461B1 (no) | 1997-06-02 |
Family
ID=8153695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941477A NO300461B1 (no) | 1991-10-24 | 1994-04-22 | 2,6-Disubstituerte purinderivater |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5432164A (OSRAM) |
| EP (1) | EP0609375A1 (OSRAM) |
| JP (1) | JPH07500586A (OSRAM) |
| AU (1) | AU657374B2 (OSRAM) |
| CA (1) | CA2121844A1 (OSRAM) |
| FI (1) | FI941876L (OSRAM) |
| IL (1) | IL103513A (OSRAM) |
| NO (1) | NO300461B1 (OSRAM) |
| NZ (1) | NZ244875A (OSRAM) |
| WO (1) | WO1993008206A1 (OSRAM) |
| ZA (1) | ZA928222B (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5432164A (en) * | 1991-10-24 | 1995-07-11 | Novo Nordisk A/S | C2,N6 -disubstituted adenosine derivatives |
| US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| EP0704215A3 (en) * | 1994-06-02 | 1998-04-01 | Takeda Chemical Industries, Ltd. | Inhibitor of vascular permeability enhancer |
| AU2022597A (en) * | 1996-03-13 | 1997-10-01 | Novo Nordisk A/S | A method of treating disorders related to cytokines in mammals |
| AU2022497A (en) * | 1996-03-13 | 1997-10-01 | Novo Nordisk A/S | A method of treating disorders related to cytokines in mammals |
| RU2172320C2 (ru) * | 1996-08-27 | 2001-08-20 | Си Ви Терапьютикс, Инк. | Производные аденозина, фармацевтическая композиция и способ коррекции электрических нарушений в сердце млекопитающего |
| US5789416B1 (en) * | 1996-08-27 | 1999-10-05 | Cv Therapeutics Inc | N6 mono heterocyclic substituted adenosine derivatives |
| WO1998016539A1 (en) * | 1996-10-14 | 1998-04-23 | Novo Nordisk A/S | Novel therapeutically active adenosine derivatives |
| US6110902A (en) * | 1997-06-23 | 2000-08-29 | Moehler; Hanns | Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine |
| US6175004B1 (en) * | 1998-09-01 | 2001-01-16 | Isis Pharmaceuticals, Inc. | Process for the synthesis of oligonucleotides incorporating 2-aminoadenosine |
| US6576619B2 (en) | 1999-05-24 | 2003-06-10 | Cv Therapeutics, Inc. | Orally active A1 adenosine receptor agonists |
| US6294522B1 (en) * | 1999-12-03 | 2001-09-25 | Cv Therapeutics, Inc. | N6 heterocyclic 8-modified adenosine derivatives |
| US7342003B2 (en) * | 2001-10-25 | 2008-03-11 | King Pharmaceuticals Research And Development, Inc. | Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs |
| WO2004069185A2 (en) * | 2003-02-03 | 2004-08-19 | Cv Therapeutics Inc. | Partial and full agonists of a1 adenosine receptors |
| WO2005033121A2 (en) * | 2003-10-03 | 2005-04-14 | King Pharmaceuticals Research & Development, Inc. | Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs |
| WO2007107598A1 (en) | 2006-03-21 | 2007-09-27 | Heinrich-Heine-Universität Düsseldorf | Phosphorylated a2a receptor agonists |
| JP6396473B2 (ja) | 2013-12-19 | 2018-09-26 | ザ プロクター アンド ギャンブル カンパニー | −ｃ（ｏｈ）−及び−ｃ（＝ｏ）ｏｈから選択される少なくとも２個の官能基を含む活性剤を使用した、ケラチン繊維の成形 |
| EP3297730A1 (en) | 2014-12-19 | 2018-03-28 | The Procter and Gamble Company | Method of shaping keratin fibres |
| MX2017008204A (es) | 2014-12-19 | 2017-10-06 | Procter & Gamble | Conformacion de las fibras de queratina mediante el uso de arabinosa y carbonato de etileno. |
| IL321433A (en) | 2022-12-16 | 2025-08-01 | Astrazeneca Ab | Purines 2,6,9 trimethylated |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3796700A (en) * | 1970-06-30 | 1974-03-12 | Takedo Chem Ind Ltd | Adenosine derivatives and the production thereof |
| JPH0696534B2 (ja) * | 1986-04-25 | 1994-11-30 | ヘキストジヤパン株式会社 | 抗痴呆剤 |
| US5017578A (en) * | 1989-06-09 | 1991-05-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents |
| PT95628A (pt) * | 1989-10-19 | 1991-09-30 | Searle & Co | Metodo de tratamento de perturbacoes de mobilidade gastrointestinal com composto de adenosina |
| US5432164A (en) * | 1991-10-24 | 1995-07-11 | Novo Nordisk A/S | C2,N6 -disubstituted adenosine derivatives |
-
1992
- 1992-10-20 US US07/963,878 patent/US5432164A/en not_active Expired - Fee Related
- 1992-10-21 WO PCT/DK1992/000307 patent/WO1993008206A1/en not_active Ceased
- 1992-10-21 CA CA002121844A patent/CA2121844A1/en not_active Abandoned
- 1992-10-21 EP EP92923113A patent/EP0609375A1/en not_active Ceased
- 1992-10-21 FI FI941876A patent/FI941876L/fi not_active Application Discontinuation
- 1992-10-21 JP JP5507362A patent/JPH07500586A/ja active Pending
- 1992-10-21 AU AU29160/92A patent/AU657374B2/en not_active Ceased
- 1992-10-22 IL IL10351392A patent/IL103513A/en not_active IP Right Cessation
- 1992-10-23 NZ NZ244875A patent/NZ244875A/en unknown
- 1992-10-23 ZA ZA928222A patent/ZA928222B/xx unknown
-
1994
- 1994-04-22 NO NO941477A patent/NO300461B1/no unknown
-
1995
- 1995-05-05 US US08/435,005 patent/US5578582A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI941876A7 (fi) | 1994-06-22 |
| US5578582A (en) | 1996-11-26 |
| IL103513A0 (en) | 1993-03-15 |
| FI941876A0 (fi) | 1994-04-22 |
| US5432164A (en) | 1995-07-11 |
| NO300461B1 (no) | 1997-06-02 |
| JPH07500586A (ja) | 1995-01-19 |
| EP0609375A1 (en) | 1994-08-10 |
| NZ244875A (en) | 1995-04-27 |
| FI941876L (fi) | 1994-06-22 |
| CA2121844A1 (en) | 1993-04-29 |
| IL103513A (en) | 1996-09-12 |
| AU657374B2 (en) | 1995-03-09 |
| WO1993008206A1 (en) | 1993-04-29 |
| AU2916092A (en) | 1993-05-21 |
| NO941477D0 (no) | 1994-04-22 |
| ZA928222B (en) | 1994-04-25 |